Reply to Scalone and Cortesi

"Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: The importance of using updated and adequate social tariffs to calculate QALYs"

Federico Spandonaro, Fabio Ayala, Enzo Berardesca, Sergio Chimenti, Giampiero Girolomoni, Patrizia Martini, Andrea Peserico, Barbara Polistena, Antonio Puglisi Guerra, Gino Antonio Vena, Gianfranco Altomare, Piergiacomo Calzavara Pinton

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)71-72
Number of pages2
JournalBioDrugs
Volume29
Issue number1
DOIs
Publication statusPublished - 2015

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Biotechnology
  • Medicine(all)

Cite this

Reply to Scalone and Cortesi : "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: The importance of using updated and adequate social tariffs to calculate QALYs". / Spandonaro, Federico; Ayala, Fabio; Berardesca, Enzo; Chimenti, Sergio; Girolomoni, Giampiero; Martini, Patrizia; Peserico, Andrea; Polistena, Barbara; Guerra, Antonio Puglisi; Vena, Gino Antonio; Altomare, Gianfranco; Pinton, Piergiacomo Calzavara.

In: BioDrugs, Vol. 29, No. 1, 2015, p. 71-72.

Research output: Contribution to journalArticle

Spandonaro, F, Ayala, F, Berardesca, E, Chimenti, S, Girolomoni, G, Martini, P, Peserico, A, Polistena, B, Guerra, AP, Vena, GA, Altomare, G & Pinton, PC 2015, 'Reply to Scalone and Cortesi: "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: The importance of using updated and adequate social tariffs to calculate QALYs"', BioDrugs, vol. 29, no. 1, pp. 71-72. https://doi.org/10.1007/s40259-015-0118-5
Spandonaro, Federico ; Ayala, Fabio ; Berardesca, Enzo ; Chimenti, Sergio ; Girolomoni, Giampiero ; Martini, Patrizia ; Peserico, Andrea ; Polistena, Barbara ; Guerra, Antonio Puglisi ; Vena, Gino Antonio ; Altomare, Gianfranco ; Pinton, Piergiacomo Calzavara. / Reply to Scalone and Cortesi : "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: The importance of using updated and adequate social tariffs to calculate QALYs". In: BioDrugs. 2015 ; Vol. 29, No. 1. pp. 71-72.
@article{474488f865e64f3f8e8c23bc6e5ec2c6,
title = "Reply to Scalone and Cortesi: {"}Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: The importance of using updated and adequate social tariffs to calculate QALYs{"}",
author = "Federico Spandonaro and Fabio Ayala and Enzo Berardesca and Sergio Chimenti and Giampiero Girolomoni and Patrizia Martini and Andrea Peserico and Barbara Polistena and Guerra, {Antonio Puglisi} and Vena, {Gino Antonio} and Gianfranco Altomare and Pinton, {Piergiacomo Calzavara}",
year = "2015",
doi = "10.1007/s40259-015-0118-5",
language = "English",
volume = "29",
pages = "71--72",
journal = "Clinical Immunotherapeutics",
issn = "1173-8804",
publisher = "Adis International Ltd",
number = "1",

}

TY - JOUR

T1 - Reply to Scalone and Cortesi

T2 - "Cost-utility analysis of biologic therapies to treat chronic plaque psoriasis in Italy: The importance of using updated and adequate social tariffs to calculate QALYs"

AU - Spandonaro, Federico

AU - Ayala, Fabio

AU - Berardesca, Enzo

AU - Chimenti, Sergio

AU - Girolomoni, Giampiero

AU - Martini, Patrizia

AU - Peserico, Andrea

AU - Polistena, Barbara

AU - Guerra, Antonio Puglisi

AU - Vena, Gino Antonio

AU - Altomare, Gianfranco

AU - Pinton, Piergiacomo Calzavara

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84925515847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925515847&partnerID=8YFLogxK

U2 - 10.1007/s40259-015-0118-5

DO - 10.1007/s40259-015-0118-5

M3 - Article

VL - 29

SP - 71

EP - 72

JO - Clinical Immunotherapeutics

JF - Clinical Immunotherapeutics

SN - 1173-8804

IS - 1

ER -